Human papillomavirus infection and risk factors in a cohort of Tuscan women aged 18-24: Results at recruitment

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Confortini, Massimo ^a   Carozzi, Francesca ^a   Zappa, Marco ^a   Ventura, Leonardo ^a   Iossa, Anna ^a   Cariaggi, Paola ^a   Brandigi, Livia ^a   Franchini, Mario ^b   Mirri, Francesco ^c   Viacava, Paolo ^d   Scarfantoni, Aurora ^d   Bazzanti, Daniela ^e   Sani, Cristina ^a  

^a ISPO   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^c Departimental Section of Cytohistological for Oncological Screening   (Italy)

^d Ospedale Unico Della Versilia   (Italy)

^e Sanitary District of Valdarno   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; COHORT ANALYSIS; COLPOSCOPY; CONDOM; CONTROLLED STUDY; CYTODIAGNOSIS; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; INFECTION RISK; ITALY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PATIENT REFERRAL; PREVALENCE; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; SEXUALITY; WART VIRUS; ADOLESCENT; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; RISK FACTOR; VAGINA SMEAR;

ADOLESCENT; ADULT; COHORT STUDIES; COLPOSCOPY; FEMALE; HUMANS; ITALY; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77953049186     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-157     Document Type: Article

References (31)

1. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV, . the International Biological Study on Cervical Cancer (IBSCC) Study Group Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst (Bethesda) 1995, 87:796-802. the International Biological Study on Cervical Cancer (IBSCC) Study Group.
2. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Muñoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19. 10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F, 10451482.
3. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh TM, Palefsky J. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. J Am Med Ass 2001, 85:2995-3002.
4. Hildesheim A, Schiffman M, Gravitt P, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manes MM. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994, 169:235-240.
5. Moscicki AB, Palefsky J, Smith G, Siboshski S, Schoolnik G. Variability of human papillomavirus DNA testing in a longitudinal cohort of young women. Obstet Gynecol 1993, 82:578-585. 10.1097/00006250-199310000-00021, 8397358.
6. Ronco G, Segnan N, Giorgi-Rossi P, Zappa M, Casadei GP, Carozzi F, Dalla Palma P, Del Mistro A, Folicaldi S, Gillio-Tos A, Nardo G, Naldoni C, Schincaglia P, Zorzi M, Confortini M, Cuzick J, . New Technologies for Cervical Cancer Working Group Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006, 98(11):765-74. 10.1093/jnci/djj209, 16757701, New Technologies for Cervical Cancer Working Group.
7. Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J, . New Technologies for Cervical Cancer screening Working Group Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol 2006, 7(7):547-55. 10.1016/S1470-2045(06)70731-8, 16814206, New Technologies for Cervical Cancer screening Working Group.
8. Ammatuna P, Giovannelli L, Matranga D, Ciriminna S, Perino A. Prevalence of genital human papilloma virus infection and genotypes among young women in Sicily, South Italy. Cancer Epidemiol Biomarkers Prev 2008, 17(8):2002-6. 10.1158/1055-9965.EPI-08-0180, 18708390.
9. Raccomandazioni per la pianificazione e l'esecuzione degli screening di popolazione per la prevenzione del cancro della mammella, del cancro della cervice uterina e del cancro del colon retto. Ministero della Salute. Roma 2006,
10. Cuschieri KS, Cubie HA, Whitley MW, Seagar AL, Arends MJ, Moore C, Gilkisson G, McGoogan E. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004, 57(1):68-72. 10.1136/jcp.57.1.68, 1770158, 14693839.
11. Tozetti IA, Scapulatempo ID, Kawski VL, Ferreira AW, Levi JE. Multiple types of human papillomavirus in cervical samples in women in Campo Grande, MS, Brazil. Braz J Infect Dis 2006, 10(5):309-10. 10.1590/S1413-86702006000500001, 17293916.
12. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T, Young N, . Forum Group Members; Bethesda 2001 Workshop The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119. 10.1001/jama.287.16.2114, 11966386, Forum Group Members; Bethesda 2001 Workshop.
13. Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, Kiviat NB. Human papillomavirus infection among sexually active women in the United States : implications for developing a vaccination strategy. Sex transm Dis 2006, 33:502-8. 10.1097/01.olq.0000204545.89516.0a, 16572039.
14. Winer R, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: invcidence and risk factors in a cohort of female university student. Am J Epidemiol 2003, 157:218-26. 10.1093/aje/kwf180, 12543621.
15. Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Gillio-Tos A, Minucci D, Naldoni C, Rizzolo R, Schincaglia P, Volante R, Zappa M, Zorzi M, Cuzick J, Segnan N, . New Technologies for Cervical Cancer Screening Working Group Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 2008, 100(7):492-501. 10.1093/jnci/djn065, 18364502, New Technologies for Cervical Cancer Screening Working Group.
16. Sandri MT, Riggio D, Salvatici M, Passerini R, Zorzino L, Boveri S, Radice D, Spolti N, Sideri M. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol 2009, 81(2):271-7. 10.1002/jmv.21382, 19107962.
17. Sideri M, Cristoforoni P, Casadio C, Boveri S, Igidbashian S, Schmitt M, Gheit T, Tommasino M. Distribution of human papillomavirus genotypes in invasive cervical cancer in Italy: a representative, single institution case series. Vaccine 2009, 27(Suppl 1):A30-3. 10.1016/j.vaccine.2008.12.028, 19480958.
18. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008, 68(21):8813-24. 10.1158/0008-5472.CAN-08-1380, 2727731, 18974124.
19. Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, Koutsky LA. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000, 182(4):1097-102. 10.1086/315805, 10979905.
20. Mendez F, Munoz N, Posso H, Molano M, Moreno V, van den Brule AJ, Ronderos M, Meijer C, Munoz A, . Instituto Nacional de Cancerologia Human Papillomavirus Study Group Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines. J Infect Dis 2005, 192(7):1158-65. 10.1086/444391, 16136457, Instituto Nacional de Cancerologia Human Papillomavirus Study Group.
21. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001, 184(12):1508-17. 10.1086/324579, 11740725.
22. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, Koutsky LA. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006, 354(25):2645-54. 10.1056/NEJMoa053284, 16790697.
23. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of a cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423-8. 10.1056/NEJM199802123380703, 9459645.
24. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine 2006, 24(Suppl 3):S42-51.
25. Karlsonn R, Jonsson M, Edlund K, Evander M, Gustavsson A, Boden E, Rylander E, Wadell G. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population based study. Sex Transm Dis 1995, 22:119-27. 10.1097/00007435-199503000-00008, 7624813.
26. Vaccarella S, Herrero R, Snijders PJ, Dai M, Thomas JO, Hieu NT, Ferreccio C, Matos E, Posso H, de Sanjosé S, Shin HR, Sukvirach S, Lazcano-Ponce E, Muñoz N, Meijer CJ, Franceschi S, . IARC HPV Prevalence Surveys (IHPS) Study Group Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 2008, 37(3):536-46. Epub 2008 Mar 3, 10.1093/ije/dyn033, 18316350, IARC HPV Prevalence Surveys (IHPS) Study Group.
27. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998, 338:423-8. 10.1056/NEJM199802123380703, 9459645.
28. Davidson M, Schnitzer PG, Bulkow LR, Parkinson AJ, Schloss ML, Fitzgerald MA, Knight JA, Murphy CM, Kiviat NB, Toomey KE. The prevalence of cervical infection with human papillomaviruses and cervical dysplasia in Alaska Native women. J Infect Dis 1994, 169:792-800.
29. Jamison JH, Kaplan DW, Hamman R, Eagar R, Beach R, Douglas JM. Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis 1995, 22:236-43. 10.1097/00007435-199507000-00007, 7482107.
30. Young TK, McNicol P, Beauvais J. Factors associated with human papillomavirus infection detected by polymerase chain reaction among urban Canadian Aboriginal and non-Aboriginal women. Sex Transm Dis 1997, 24:293-8. 10.1097/00007435-199705000-00011, 9153740.
31. Kjaer SK, Svare EI, Worm AM, Walboomers JM, Meijer CJ, van den Brule AJ. Human papillomavirus infection in Danish female sex workers: decreasing prevalence with age despite continuously high sexual activity. Sex Transm Dis 2000, 27(4):38-45.